AlphaQuest’s Emergent Biosolutions EBS Stock Holding History

AlphaQuest’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,549	Closed	-$19.1K	–	619
2025 Q4	$19.1K	Sell	1,549 -18,248	-92%	-$196K	﹤0.01%	2098
2025 Q3	$175K	Buy	+19,797	New	+$154K	0.01%	1474

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AlphaQuest's EBS Position: Q1 2026 in Review

AlphaQuest sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 1,549 shares — an estimated $19.1K sold.

AlphaQuest first reported a position in EBS in Q3 2025 and held it in 2 quarters. The position peaked at $175K in Q3 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

AlphaQuest reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 1,549 Emergent Biosolutions shares in Q1 2026, an estimated $19.1K.
AlphaQuest first reported a position in Emergent Biosolutions in Q3 2025 and held it in 2 quarters.
AlphaQuest's Emergent Biosolutions position peaked at $175K in Q3 2025.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.